Chunying Zhuang, Xiaoxiao Liu, Yuting Song, Ping He, Dan Zheng, Xi Yan, Xiaorong Zhong, Tinglun Tian, Bing Wei, Yu Xin Xie, Jie Chen, Qing Lv, Ting Luo. "Camrelizumab plus apatinib and chemotherapy as neoadjuvant therapy for triple negative breast cancer (TNBC): A single-arm, prospective phase II study (MA-BC-II-026).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e12623